INTRODUCTION Tecartus is a new advanced therapy approved to treat adults with mantle cell lymphoma (MCL)¹. This disease is a lymphatic system cancer. Specifically, it
INTRODUCTION Kymriah (Novartis) is an advanced therapy medicine that belongs to the gene therapyproduct category. It is approved for B-cell acute lymphoblastic leukemia (ALL) in
INTRODUCTION ¹. CARVYKTI™ (ciltacabtagene autoleucel – Johnson & Johnson) was approved by the U.S. Food and Drug Administration (FDA) in February 2022 for the treatment
INTRODUCTION Tecartus is a new advanced therapy approved to treat adults with mantle cell lymphoma (MCL)¹. This disease is a lymphatic system cancer. Specifically, it
INTRODUCTION Kymriah (Novartis) is an advanced therapy medicine that belongs to the gene therapyproduct category. It is approved for B-cell acute lymphoblastic leukemia (ALL) in
INTRODUCTION ¹. CARVYKTI™ (ciltacabtagene autoleucel – Johnson & Johnson) was approved by the U.S. Food and Drug Administration (FDA) in February 2022 for the treatment
Ultrasound and magnetic resonance imaging (MRI) are frequent tools to evaluate if an area is a tumor candidate. However, in most cases, the only way
Are solar panels safe? Solar panels are placed on the roofs of buildings or in solar farms. Some people wonder whether the technology used to
WHAT IS IMMUNOTHERAPY? Immunotherapy is a type of cancer treatment that increases the body’s natural defenses to fight cancer. It improves the immune system’s ability
Geistek Pharmaceuticals y el fondo de inversión Nowture llegan a un acuerdo para la promoción del ecosistema Life Science en España Geistek Pharmaceuticals llega a
Polémica aprobación por parte de la FDA del primer fármaco para la Enfermedad de Alzheimer en 20 años El Alzheimer (EA) es una enfermedad neurodegenerativa
El diseño de ensayos clínicos es un mundo muy complejo que requiere de personal altamente cualificado para poder elegir la mejor estrategia posible. La Medicina
¿Qué es la vía PRIME? La vía PRIME fue propuesta por la Agencia Europea del Medicamento (EMA) en marzo de 2016 con el objetivo de
The severe acute respiratory syndrome caused by the coronavirus 2 (SARS-CoV-2) emerged in December 2019 causing a global pandemic. COVID-19 progression is generally biphasic, initially
Classic homocystinuria due to cystationine beta synthase deficiency is an autosomal recessive disease that affects 1 to 9 of every 100,000 newborns, but is detected
